Population-based screening in colorectal cancer - current practice and future developments: faecal biomarkers review.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Gastrointestinal and Liver Diseases

• Publication date

  2014-06-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.15403/JGLD.2014.1121.232.DSW1PMID 24949612
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development and Validation of a Risk Stratification-based Screening Model for Predicting Colorectal Advanced Neoplasia in Korea

  2015cited by this paper
• Key considerations for the experimental training and evaluation of cancer odour detection dogs: lessons learnt from a double-blind, controlled trial of prostate cancer detection

  2014cited by this paper
• Endoscopic innovations to increase the adenoma detection rate during colonoscopy.

  2014cited by this paper
• Comparison of the accuracy of CT colonography and colonoscopy in the diagnosis of colorectal cancer

  2014cited by this paper
• Personalizing colorectal cancer screening: a systematic review of models to predict risk of colorectal neoplasia.

  2014cited by this paper
• Colorectal cancer prevention in Europe: burden of disease and status of screening programs.

  2014influential reference
• Sensitivity and specificity of CT colonography for the detection of colonic neoplasia after positive faecal occult blood testing: systematic review and meta-analysis

  2014cited by this paper
• Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography: study protocol for a multicenter randomized trial

  2014cited by this paper
• Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study

  2014cited by this paper
• The liver breath! Breath volatile organic compounds for the diagnosis of liver disease.

  2014cited by this paper
• Screening for colorectal cancer with FOBT, virtual colonoscopy and optical colonoscopy: study protocol for a randomized controlled trial in the Florence district (SAVE study)

  2013cited by this paper
• Public preferences for colorectal cancer screening tests: a review of conjoint analysis studies

  2013cited by this paper
• Outcome of 12‐month surveillance colonoscopy in high‐risk patients in the National Health Service Bowel Cancer Screening Programme

  2013influential reference
• Patients’ Preferences and Priorities Regarding Colorectal Cancer Screening

  2013cited by this paper
• An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel Syndrome

  2013cited by this paper
• Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals.

  2013cited by this paper
• Diagnostic value of stool DNA testing for multiple markers of colorectal cancer and advanced adenoma: a meta-analysis.

  2013influential reference
• Fecal miR-106a Is a Useful Marker for Colorectal Cancer Patients with False-Negative Results in Immunochemical Fecal Occult Blood Test

  2013cited by this paper
• MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment.

  2013influential reference
• Economic evaluation of colorectal cancer (CRC) screening.

  2013cited by this paper
• The National Health Service Bowel Cancer Screening Program: the early years

  2013cited by this paper
• Radiation risk from CT: implications for cancer screening.

  2013cited by this paper
• Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

  2013cited by this paper
• Diagnostic value of fecal tumor M2‐pyruvate kinase for CRC screening: A systematic review and meta‐analysis

  2012cited by this paper
• European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication

  2012cited by this paper
• Screening CT colonography: multicenter survey of patient experience, preference, and potential impact on adherence.

  2012cited by this paper
• Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis.

  2012cited by this paper
• Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study

  2012cited by this paper
• Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: a meta-analysis.

  2012cited by this paper
• Tailoring colorectal cancer screening by considering risk of advanced proximal neoplasia.

  2012cited by this paper
• Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test

  2012cited by this paper
• [Korean guidelines for colorectal cancer screening and polyp detection].

  2012cited by this paper
• Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.

  2012influential reference
• Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.

  2012influential reference
• Systematic review and meta‐analysis of the evidence for flexible sigmoidoscopy as a screening method for the prevention of colorectal cancer

  2012cited by this paper
• Next-generation stool DNA test accurately detects colorectal cancer and large adenomas.

  2012cited by this paper
• COST-EFFECTIVENESS OF COMPUTED TOMOGRAPHY COLONOGRAPHY IN COLORECTAL CANCER SCREENING: A SYSTEMATIC REVIEW

  2012cited by this paper
• Colorectal Cancer Screening: Practice Guidelines

  2012cited by this paper
• Korean Guidelines for Colorectal Cancer Screening and Polyp Detection

  2012cited by this paper
• Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: A meta‐analysis

  2011cited by this paper
• Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening.

  2011cited by this paper
• Radiation-related cancer risks from CT colonography screening: a risk-benefit analysis.

  2011cited by this paper
• Colorectal cancer: CT colonography and colonoscopy for detection--systematic review and meta-analysis.

  2011cited by this paper
• Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme

  2011influential reference
• Flexible Sigmoidoscopy Does Not Significantly Increase Polyp and Cancer Detection Yield when Used to Supplement CT Colonography

  2011cited by this paper
• Differential expression of miR-144* as a novel fecal-based diagnostic marker for colorectal cancer

  2011cited by this paper
• Burden of colonoscopy compared to non-cathartic CT-colonography in a colorectal cancer screening programme: randomised controlled trial

  2011cited by this paper
• Colorectal cancer screening with odour material by canine scent detection

  2011cited by this paper
• Colorectal cancer molecular biology moves into clinical practice

  2010cited by this paper
• Comparison of immunochemical and guaiac‐based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: A meta‐analysis

  2010influential reference
• MicroRNA Expression Profiling of Exfoliated Colonocytes Isolated from Feces for Colorectal Cancer Screening

  2010cited by this paper
• Evidence for colorectal cancer screening.

  2010cited by this paper
• [Colorectal cancer screening].

  2010cited by this paper
• Cost effectiveness of CT colonography for UK NHS colorectal cancer screening of asymptomatic adults aged 60–69 years

  2010cited by this paper
• Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial.

  2010cited by this paper
• Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests

  2010influential reference
• Sex Differences in Performance of Fecal Occult Blood Testing

  2010cited by this paper
• Risk analyses for screening sigmoidoscopy based on a colorectal cancer (CRC) population

  2009cited by this paper
• Volatile organic compounds as diagnostic biomarkers in gastrointestinal and liver diseases.

  2009cited by this paper
• Metabolite profiling of fecal water extracts from human colorectal cancer

  2009cited by this paper
• Appropriateness of colonoscopy in Europe (EPAGE II) – Screening for colorectal cancer

  2009cited by this paper
• Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy

  2009cited by this paper
• Approaches to improving breast screening uptake: evidence and experience from Tower Hamlets

  2009cited by this paper
• Comparison of CT colonography, colonoscopy, sigmoidoscopy and fecal occult blood tests for the detection of advanced adenoma in an average risk population

  2009cited by this paper
• Colorectal cancer screening in Europe.

  2009cited by this paper
• Clusterin in Stool: A New Biomarker for Colon Cancer Screening?

  2009cited by this paper
• Association of Colonoscopy and Death From Colorectal Cancer

  2009cited by this paper
• American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008

  2009cited by this paper
• Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.

  2008cited by this paper
• Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases

  2008cited by this paper
• Evaluation of Calgranulin B in Stools from the Patients with Colorectal Cancer

  2008cited by this paper
• Asia Pacific consensus recommendations for colorectal cancer screening

  2008cited by this paper
• Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps.

  2008cited by this paper
• Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology * †

  2008cited by this paper
• Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.

  2008cited by this paper
• A cohort effect in cervical screening coverage?

  2008cited by this paper
• Preferences for Colorectal Cancer Screening Among Racially/Ethnically Diverse Primary Care Patients

  2008cited by this paper
• Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population

  2008cited by this paper
• Colorectal cancer screening world gastroenterology organisation/international digestive cancer alliance practice guidelines

  2008cited by this paper
• Cost‐effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia

  2008cited by this paper
• Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

  2008cited by this paper
• Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programme

  2008cited by this paper
• Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review

  2007cited by this paper
• Improved fecal DNA test for colorectal cancer screening.

  2007cited by this paper
• Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

  2007influential reference
• Usefulness of fecal lactoferrin and hemoglobin in diagnosis of colorectal diseases.

  2007cited by this paper
• Tumor pyruvate kinase isoenzyme type M2 and immunochemical fecal occult blood test: performance in screening for colorectal cancer

  2007cited by this paper
• Option appraisal of population-based colorectal cancer screening programmes in England

  2006cited by this paper
• Diagnostic value of faecal calprotectin in unselected outpatients referred for colonoscopy: A multicenter prospective study.

  2006cited by this paper
• Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries

  2006cited by this paper
• Incidence of colonic perforation at CT colonography: review of existing data and implications for screening of asymptomatic adults.

  2006cited by this paper
• Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison

  2005cited by this paper
• Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison.

  2005cited by this paper
• Meta-Analysis: Computed Tomographic Colonography

  2005cited by this paper
• Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer

  2003cited by this paper
• Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen.

  2003cited by this paper
• Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool.

  2002cited by this paper
• Accuracy of polyp detection by gastroenterologists and nurse endoscopists during flexible sigmoidoscopy: a randomized trial.

  1999cited by this paper
• Colon cancer at barium enema examination and colonoscopy: a study from the county of Hordaland, Norway.

  1999cited by this paper
• A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult.

  1998cited by this paper

• Mucins as Potential Biomarkers for Early Detection of Cancer

  2023cites this paper
• Association of TM6SF2 rs58542926 gene polymorphism with the risk of non-alcoholic fatty liver disease and colorectal adenoma in Chinese Han population

  2019cites this paper
• Association between NAFLD and Risk of Colorectal Adenoma in Chinese Han Population

  2019cites this paper
• An integrated lncRNA, microRNA and mRNA signature to improve prognosis prediction of colorectal cancer

  2017cites this paper
• An investigation of volatile organic compounds as biomarkers for gastrointestinal neoplasia

  2017cites this paper
• Local staging and assessment of colon cancer with 1.5-T magnetic resonance imaging.

  2016cites this paper
• Decreased MALL expression negatively impacts colorectal cancer patient survival

  2016cites this paper
• Correlation between Faecal Tumour M2 Pyruvate Kinase and Colonoscopy for the Detection of Adenomatous Neoplasia in a Secondary Care Cohort.

  2016cites this paper
• Local staging and assessment of colon cancer with 1.5-T magnetic resonance imaging

  2016cites this paper
• Opportunistic colorectal cancer screening using colonoscopy. Comparative results between two historical cohorts in Bucharest, Romania.

  2015cites this paper
• Association between nonalcoholic fatty liver disease and colorectal adenoma: a systematic review and meta-analysis.

  2015cites this paper
• Original Article Association between nonalcoholic fatty liver disease and colorectal adenoma: a systematic review and meta-analysis

  2015cites this paper